Skip to main content

Table 6 Analysis of MSI and MLH1 or MGMT methylation

From: Correlation of MLH1 and MGMTexpression and promoter methylation with genomic instability in patients with thyroid carcinoma

Methylated and MSI

PTC

FTC

Benign

N (%)

N (%)

N (%)

MLH1

24/31 (77%)*

3/4 (75%)

4/9 (44%)

MGMT

38/45 (84%)**

7/8 (87%)

3/8 (37%)

  1. *p = 0.079 compared with the benign group; **p = 0.01.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us